Skip to content

Effect of hypercapnia on cognitive function in patients undergoing non-intubated spontaneous-ventilation video-assisted thoracoscopic surgery

Effect of hypercapnia on cognitive function in patients undergoing non-intubated spontaneous-ventilation video-assisted thoracoscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042381
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

PETCO245-55mmHg:none
PETCO255-65mmHg:none
PETCO265-75mmHg:none

Sponsors

Yunnan First People's Hospital Affiliated to Kunming University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who underwent single wedge lung resection; 2. Subjects with operation time < 2 hours and intraoperative blood loss < 300 ml; 3. Subjects without extensive thoracic adhesions; 4. ASA I - II subjects; 5. Subjects without other contraindications of paravertebral nerve block and intercostal nerve block.

Exclusion criteria

Exclusion criteria: 1. The subjects who refused the operation or anesthesia plan had a history of thoracoscopic surgery; 2. Patients with moderate to severe chronic obstructive pulmonary disease (COPD) had preoperative hypoxemia (PaO2 50 mmHg) and severe acute pulmonary infection; 3. Patients with arrhythmia indicated by preoperative examination have cardiac insufficiency; 4. Coagulation dysfunction in patients with local anesthetic allergy; 5. Subjects with body mass index (BMI) > 28 kg / m2; 6. Patients with extensive pleural adhesion or complicated lobectomy or segmental resection; 7. Patients transferred to double lumen endotracheal tube or thoracotomy; 8. Patients with neuropsychiatric diseases or other important organ dysfunction.

Design outcomes

Primary

MeasureTime frame
concentration of Aß-42 and S100ß in the serum;cerebral oxygen saturation;concentration of inflammatory factor in the serum;mini- mental state examination;

Secondary

MeasureTime frame
the time of tracheal catheter removal;PACU retention;the incidence of adverse reactions;

Countries

China

Contacts

Public ContactHua Jin

Yunnan First People's Hospital Affiliated to Kunming University of Science and Technology

jinhuakm@163.com+86 13888668869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026